通过对T细胞重定向双特异性抗体的聚合物对目标独立的免疫细胞激活
Minoru Tada1, Michihiko Aoyama1, Akiko Ishii-Watabe1
1Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Kanagawa, Japan.
Journal of pharmaceutical sciences
|July 1, 2023
概括
HER2-CD3双特异性抗体 (bsAbs) 的聚合可以直接激活免疫细胞,导致细胞因子的释放. 这突显了癌症免疫疗法中聚合bsAbs的意外免疫激活和不良反应的风险.
科学领域:
- 免疫学 免疫学 免疫学
- 生物治疗学 生物治疗学
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 重定向T细胞双特异性抗体 (bsAbs) 是癌症免疫疗法的一类有前途的生物疗法.
- 这些bsAbs使T细胞向瘤细胞,调解癌细胞的死亡.
研究的目的:
- 评估聚合对HER2-CD3双特异抗体 (bsAb) 体内免疫毒性的影响.
主要方法:
- 准备一个Tandem scFv型的HER2-CD3 bsAb.
- 基于细胞的测试使用CD3表达记者细胞和人体外周血液单核细胞 (hPBMCs).
- 使用定量激光衍射 (qLD) 分析聚合物.
主要成果:
- HER2-CD3 bsAb聚合物直接激活了没有细胞的CD3表达性免疫细胞.
- 聚合物中的不溶性蛋白质颗粒,含有功能域,有助于免疫细胞激活.
- 聚合物刺激hPBMCs,诱导炎症性细胞因子和化学因子的显著分泌.
结论:
- 聚合T细胞重定向的bsAbs存在意外免疫细胞激活和炎症的风险.
- 这种聚合可以导致免疫介导的不良反应.
- 仔细控制bsAb聚合对于安全有效的癌症免疫疗法至关重要.
相关概念视频
T Cell Activation and Clonal Selection
832
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
832
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Cytotoxic T Cells-mediated Immune Response
995
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
995


